Table 1. Baseline characteristics of the patients included and peri-operative/histological details.
| Characteristic | TL-NSRH (n=170) | OA-NSRH (n=131) | p-value | |
|---|---|---|---|---|
| Age (yr) | 48 (26–78) | 50 (26–79) | 0.259 | |
| BMI (kg/m2) | 22.6 (17.5–40) | 22.9 (17.1–39) | 0.653 | |
| Stage | 0.085 | |||
| IA2 | 34 (20) | 18 (13.7) | ||
| IB1 | 78 (45.9) | 56 (42.7) | ||
| IB2 | 17 (10) | 24 (18.3) | ||
| IIA | 18 (10.6) | 23 (17.6) | ||
| IIB | 17 (10) | 10 (7.6) | ||
| Grading | 0.654 | |||
| 1 | 16 (9.4) | 10 (7.6) | ||
| 2 | 107 (62.9) | 89 (67.9) | ||
| 3 | 47 (27.6) | 32 (24.4) | ||
| Histology | 0.066 | |||
| Squamous | 122 (71.8) | 109 (83.2) | ||
| Adenocarcinoma | 40 (23.5) | 18 (13.7) | ||
| Others | 8 (4.7) | 4 (3.1) | ||
| Lymphovascular space involvement | 42 (24.7) | 29 (22.1) | >0.999 | |
| Neoadjuvant chemotherapy | 51 (30) | 50 (38.2) | 0.137 | |
| Operative time (min) | 208 (95–350) | 220 (100–400) | 0.453 | |
| Blood loss (mL) | 200 (20–1,400) | 400 (50–1,400) | 0.009 | |
| Hospital stay (days) | 3 (2–31) | 5 (4–28) | 0.007 | |
| Pelvic lymphadenectomy | 170 (100) | 131 (100) | >0.999 | |
| No. of pelvic nodes removed | 22 (1–65) | 21 (8–70) | 0.723 | |
| Patients with positive pelvic nodes | 33 (20.9) | 30 (22.9) | 0.476 | |
| Para-aortic lymphadenectomy | 27 (15.9) | 29 (22.1) | 0.179 | |
| No. of para-aortic nodes removed | 18 (4–40) | 13 (1–40) | 0.338 | |
| Patients with positive para-aortic nodes | 9 (5.5) | 10 (7.6) | 0.480 | |
| Adjuvant therapy | 72 (42.4) | 69 (52.6) | 0.076 | |
| Recurrence | 20 (11.8) | 11 (8.4) | 0.341 | |
| Dead of disease | 14 (8.2) | 9 (6.9) | 0.825 | |
Values are presented as median (interquartile range) or number (%).
OA-NSRH, open abdominal; TL-NSRH, total laparoscopic nerve-sparing radical hysterectomy.